Chimerix (CMRX)
(Delayed Data from NSDQ)
$0.82 USD
-0.01 (-1.18%)
Updated Aug 9, 2024 03:59 PM ET
After-Market: $0.81 -0.01 (-1.23%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Chimerix, Inc. [CMRX]
Reports for Purchase
Showing records 61 - 80 ( 116 total )
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Deep Dive Into ONC201 in Recurrent H3 K27M-mutant DMG Data at Society for Neuro-Oncology Annual Meeting; Raising PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Positive Data Announced For ONC201 in Recurrent H3 K27M-mutant Diffuse Midline Glioma
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
3Q21 Results; Positive ONC201 Data Readout; RFP for Smallpox Strategic National Stockpile Contract Expected Soon
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
2Q21 Results; DSTAT in AML Efficacy Analysis in 2H22; Potential Small Pox RFP Approaching
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
Company: Chimerix, Inc.
Industry: Medical - Products
Smallpox Beware: TEMBEXA Receives FDA Approval
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Chimerix, Inc.
Industry: Medical - Products
Tembexa Approved For Smallpox; Raising Price Target to $19
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E
Company: Chimerix, Inc.
Industry: Medical - Products
ASCO 2021 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Chimerix, Inc.
Industry: Medical - Products
Continued DSTAT Focus on AML as COVID-19 Trial Stopped; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: WHITE E